Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · IEX Real-Time Price · USD
13.48
+0.21 (1.58%)
Apr 24, 2024, 2:09 PM EDT - Market open
Assembly Biosciences Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for ASMB.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for ASMB is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $30 → $18 | Hold | Maintains | $30 → $18 | +33.53% | Mar 24, 2023 |
| Mizuho | Mizuho | Strong Buy Maintains $168 → $36 | Strong Buy | Maintains | $168 → $36 | +167.06% | Nov 16, 2022 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $132 → $24 | Strong Buy → Hold | Downgrades | $132 → $24 | +78.04% | Oct 24, 2022 |
| Truist Securities | Truist Securities | Strong Buy Maintains $180 → $144 | Strong Buy | Maintains | $180 → $144 | +968.25% | Apr 1, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-15.18
from -13.38
EPS Next Year
-16.08
from -15.18
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 110.3M | 228.9M | 307.7M |
| Avg | n/a | n/a | 53.6M | 111.2M | 149.4M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 327.5% | 176.7% |
| Avg | - | - | - | 107.6% | 34.4% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -15.62 | -16.55 | -17.52 | -0.25 | 0.09 |
| Avg | -15.18 | -16.08 | -17.02 | -0.71 | -0.53 |
| Low | -14.58 | -15.44 | -16.36 | -1.14 | -1.10 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.